Tag: COVID-19
IHF to support OmiX iAMP, a LAMP-based platform for combined testing...
OmiX iAMP is a multiplex platform-based test that can accurately detect Covid-19, TB, Influenza and, thereby, address detection dilemmas faced by physicians in diagnosing diseases with similar symptoms.............................
Andhra govt achieves 97% first dose Covid vaccination for 45+ citizens
Chief Minister of Andhra Pradesh, Mr. YS Jagan Mohan Reddy conducted a review meeting with the health department of the state..................
India Exim Bank engages with Indian Pharma companies to promote exports
The webinar part of the series of market interactions by India Exim Bank to address the requirements of Pharma companies working in the COVID ecosystem..........................
Ayurgenomics: IISER Bhopal sequences Giloy genome for the first time globally
Used widely during COVID-19 pandemic, Giloy as herbal medicine, has major applications in pharmaceuticals and ayurvedic formulations to treat various health conditions...........................
Over 1 crore doses in a single day: India repeats Covid-19...
With the administration of 1,33,18,718 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has surpassed the cumulative figure of 65.41 Cr (65,41,13,508) as per provisional reports..............................
India’s cumulative COVID-19 vaccination coverage inches closer to 63.5 crore doses
With 42,909 New Cases reported in the last 24 hours, India's active caseload (3,76,324) is 1.15% of total cases
Bharat Biotech unveils first commercial batch of COVAXIN manufactured in Ankleshwar
The vaccine batches manufactured from Ankleshwar facilities in Gujarat will be available for supplies starting September 2021.........................
India’s first mRNA-based Covid-19 vaccine gets DCGI nod for Phase II...
The trial for India’s first mRNA-based vaccine from Gennova Biopharmaceuticals was found to be safe in Phase I study. Post Drugs Controller General of India approval, Phase II and Phase III trials are to commence in early September, 2021......................
Agilent contributes to COVID-19 research efforts in India
Initiative will help support hospitals and universities further COVID-19 research....................
India achieves milestone of 50 crore COVID-19 sample testing
Enhanced production of diagnostic kits has resulted in reduction of costs and improved availability of testing kits. With the number of COVID-19 testing laboratories at more than 2800, last 10 crores sample testing conducted in 55 days.......................